Product Code: KLN FDA class 2 21 CFR 862.3250

Radioimmunoassay, Cocaine Metabolite

Clinical Toxicology

The Cocaine Metabolite Radioimmunoassay is an in vitro diagnostic test used in clinical toxicology laboratories to detect and quantify cocaine metabolites (primarily benzoylecgonine) in urine or other biological specimens, used for drug screening and confirmation purposes. It is classified as FDA Class 2, indicating moderate risk requiring 510(k) premarket clearance. The product code is KLN and it is regulated under 21 CFR 862.3250 in the Clinical Toxicology specialty. This device is eligible for third-party review.

510(k)s
14
FEI Numbers
0
Registration Numbers
0
Unique Applicants
7
Years Active
19

Research product code KLN in seconds

The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.

Free to try · every answer cites its records

Basic Information

Product Code
KLN
Device Class
FDA class 2
Regulation Number
862.3250
Medical Specialty
Clinical Toxicology
Review Panel
TX
Submission Type
1

Device Characteristics

GMP Exempt
Implant
Life Sustain/Support
Third Party
Summary Malfunction Reporting

510(k) Clearance History

Loading...

Related 510(k) Clearances

This FDA classification is associated with 14 510(k) clearances via K numbers.

K Number Device Name
K010868 PSYCHEMEDICS RIA COCAINE ASSAY
K913867 URINE COCAINE METABOLITE DIRECT RIA KIT (I-125)
K913722 ABUSCREEN(R) RADIOIMMUN FOR COCAINE METABOLITE
K912756 ABUSCREEN RADIOIMMUNOASSAY FOR COCAINE METABOLITE
K910123 TARGET COCAINE METABOLITE-V
K910122 TARGET COCAINE METABOLITE-R
K910044 MILENIA COCAINE METABOLITE
K905730 ABUSCREEN ONTRAK FOR COCAINE (200NG/ML)
K904995 ABUSCREEN ONLINE TM FOR COCAINE METABOLITE
K880674 MICROMEDIC CRACKPOT RIA KIT
K871549 RESUB. URINE COCAINE META. DIRECT RIA KIT [I-125]
K870740 COAT-A-COUNT COCAINE METABOLITE TKCN1 & TKCN5
K862218 DOUBLE ANTIBODY COCAINE METABOLITE RIA KIT
K830480 ABUSCREEN RADIOIMMUNOASSAY-COCAINE META